Skip to main content
. 2020 Jan 20;10(1):e030266. doi: 10.1136/bmjopen-2019-030266

Figure 2.

Figure 2

Pooled risk ratios for all-cause mortality in patients with extended-spectrum beta-lactamase (ESBL) bloodstream infections compared with patients with non-ESBL bloodstream infections—subgroups not included in attributable mortality.